Discover How Helix is Changing the World of Healthcare
Resources Hub
Helix recognized as "Top Genomics Company Accelerating Research and Discovery"
Our Top Viral Surveillance Insights in Mid-August
Our Top Viral Surveillance Insights in Early August
Helix SARS-CoV-2 Test with a Locker System Receives FDA Emergency Use Authorization (EUA)
Meeting the Quadruple Aim: The Business Value of Implementing Pharmacogenomics
Power Window Method Improves the Ability to Evaluate Clinical Impact by 2.4x
Helix Named One of the Top 100 Healthcare Technology Companies of 2022
A Power-based Sliding Window Approach to Evaluate the Clinical Impact of Rare Genetic Variants
The Latest Content From Helix
Recent Blog Posts
View All Blog Posts
Blog
Population Genomics: Personalizing Genetic Breast Cancer Screening
Blog
Unraveling the Power of Germline Clinico-Genomic Data: A Game Changer in Pharma's Drug Development Lifecycle
Blog
Preventable hospitalizations with increased oral SARS-CoV-2 antiviral treatment
Blog
What You Need to Know About the Newly Updated ASCO-SSO Guidelines
Recent Press Releases
View All Press ReleasesPress Releases
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
Press Releases
Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward
Press Releases
Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients
Recent Videos
View All Videos
Recent Published Research
View All Published Research1
Published Research
Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes
2
Published Research
Helix Debuts Novel Precision Effectiveness Model That Predicts 12-Month Weight Loss Response of Semaglutide in Diverse Populations
3
Published Research
A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort
4
Published Research
Influence of BMI-associated genetic variants and metabolic risk factors on weight loss with semaglutide: a longitudinal clinico-genomic cohort study
5
Published Research